Alcohol and the Cardiovascular System: A Double-Edged Sword

被引:25
作者
Katsiki, Niki [1 ]
Tziomalos, Konstantinos [2 ]
Mikhailidis, Dimitri P. [3 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Hippokration Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[2] UCL, Sch Med, Propedeut Dept Internal Med 1, AHEPA Hosp, London NW3 2QG, England
[3] UCL, Sch Med, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
关键词
Alcohol; cardiovascular disease; cardiovascular risk factors; diabetes; lipids; metabolic syndrome; statins; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; FATTY LIVER-DISEASE; RED WINE CONSUMPTION; C-REACTIVE PROTEIN; PERIPHERAL ARTERIAL-DISEASE; ACUTE MYOCARDIAL-INFARCTION; SLEEP-APNEA SYNDROME; LIFE-STYLE FACTORS; MODERATE ALCOHOL;
D O I
10.2174/1381612820666140620125741
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Low to moderate alcohol intake has been associated with beneficial effects on the heart and the vasculature, including improvements in several established and emerging cardiovascular disease (CVD) risk factors as well as reduced risk for several metabolic diseases, CVD morbidity and mortality. Binge and heavy drinking exert the opposite effects, leading to increased risks for all the above conditions. With regard to beverage type, there is some evidence supporting red wine superiority in cardioprotection, although other beverages have also been reported to exert beneficial metabolic and vascular effects when consumed in moderate amounts. In this narrative review we discuss the associations between alcohol consumption and CVD morbidity and mortality. Alcohol-induced effects on established and emerging CVD risk factors are also discussed taking into consideration different drinking patterns. Physicians should screen for excessive alcohol use and advise individuals to limit their alcohol intake to moderate amounts (up to 20-30 g/day for men and 10-20 g/day for women), preferably consumed with meals. The question of whether alcohol intake should be encouraged as a measure to prevent CVD remains unanswered.
引用
收藏
页码:6276 / 6288
页数:13
相关论文
共 283 条
[1]   Cardioprotective effects of light-moderate consumption of alcohol: A review of putative mechanisms [J].
Agarwal, DP .
ALCOHOL AND ALCOHOLISM, 2002, 37 (05) :409-415
[2]   Comparative Study of the Efficacy of Ascorbic Acid, Quercetin, and Thiamine for Reversing Ethanol-Induced Toxicity [J].
Ambadath, Vidhya ;
Venu, Renju Gopal ;
Madambath, Indira .
JOURNAL OF MEDICINAL FOOD, 2010, 13 (06) :1485-1489
[3]   Masked Hypertension: Evaluation, Prognosis, and Treatment [J].
Angeli, Fabio ;
Reboldi, Gianpaolo ;
Verdecchia, Paolo .
AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (09) :941-948
[4]  
[Anonymous], STROKE
[5]  
[Anonymous], AM J HYPERTENS
[6]   Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and Cancer [J].
Arranz, Sara ;
Chiva-Blanch, Gemma ;
Valderas-Martinez, Palmira ;
Medina-Remon, Alex ;
Lamuela-Raventos, Rosa M. ;
Estruch, Ramon .
NUTRIENTS, 2012, 4 (07) :759-781
[7]   Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug [J].
Asmaro, Karam ;
Fu, Paul ;
Ding, Yuchuan .
CURRENT DRUG TARGETS, 2013, 14 (01) :74-80
[8]   Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors [J].
Athyros, V. G. ;
Kakafika, A. I. ;
Papageorgiou, A. A. ;
Tziomalos, K. ;
Peletidou, A. ;
Vosikis, C. ;
Karagiannis, A. ;
Mikhailidis, D. P. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (03) :213-221
[9]   Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort [J].
Athyros, Vasilios G. ;
Liberopoulos, Evangelos N. ;
Mikhailidis, Dimitri P. ;
Papageorgiou, Athanasios A. ;
Ganotakis, Emmanuel S. ;
Tziomalos, Konstantinos ;
Kakafika, Anna I. ;
Karagiannis, Asterios ;
Lambropoulos, Stylianos ;
Elisaf, Moses .
ANGIOLOGY, 2007, 58 (06) :689-697
[10]  
Athyros VG, 2012, CURR VASC PHARMACOL, V10, P374